# Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET)

> **NCT05558644** · NA · RECRUITING · sponsor: **Institut Curie** · enrollment: 50 (estimated)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** single arm for all patients

## Key facts

- **NCT ID:** NCT05558644
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-03
- **Primary completion:** 2026-10-05
- **Final completion:** 2026-10-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05558644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05558644, "Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05558644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*